Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Martiat

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|May 1, 1993
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapseN C Cross, T P Hughes, L Feng, et al.
Leukemia|November 1, 1990
P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myelomaP Martiat, C Mecucci, Y Nizet, et al.
Bone Marrow Transplantation|April 1, 1991
Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remissionA Ferrant, C Doyen, A Delannoy, et al.
Blood|September 1, 1993
Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reactionY Nizet, S Van Daele, P Lewalle, et al.
Lancet (London, England)|April 28, 1990
False-positive results with PCR to detect leukaemia-specific transcriptT Hughes, J W Janssen, G Morgan, et al.
Blood|October 1, 1989
Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patientsA Cuneo, C Mecucci, S Kerim, et al.
Leukemia|February 9, 2007
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformationH Akl, B M Badran, N El Zein, et al.
British Journal of Haematology|October 1, 1991
Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcomeY Nizet, P Martiat, J L Vaerman, et al.
Cancer Genetics and Cytogenetics|July 15, 1996
ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemiaJ Dierlamm, L Michaux, N Kröger, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted managementP Lewalle, A Delforge, M Aoun, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|May 1, 1993
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapseN C Cross, T P Hughes, L Feng, et al.
Leukemia|November 1, 1990
P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myelomaP Martiat, C Mecucci, Y Nizet, et al.
Bone Marrow Transplantation|April 1, 1991
Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remissionA Ferrant, C Doyen, A Delannoy, et al.
Blood|September 1, 1993
Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reactionY Nizet, S Van Daele, P Lewalle, et al.
Lancet (London, England)|April 28, 1990
False-positive results with PCR to detect leukaemia-specific transcriptT Hughes, J W Janssen, G Morgan, et al.
Blood|October 1, 1989
Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patientsA Cuneo, C Mecucci, S Kerim, et al.
Leukemia|February 9, 2007
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformationH Akl, B M Badran, N El Zein, et al.
British Journal of Haematology|October 1, 1991
Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcomeY Nizet, P Martiat, J L Vaerman, et al.
Cancer Genetics and Cytogenetics|July 15, 1996
ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemiaJ Dierlamm, L Michaux, N Kröger, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted managementP Lewalle, A Delforge, M Aoun, et al.
Pageof 8